In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells
- 18 February 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (4) , 1166-1171
- https://doi.org/10.1073/pnas.94.4.1166
Abstract
The metabolic control of respiration is still poorly understood, due mainly to the lack of suitable approaches for studying it in vivo. Experiments on isolated mammalian mitochondria have indicated that a relatively small fraction of each of several components of the electron transport chain is sufficient to sustain a normal O2 consumption rate. These experiments, however, may not reflect accurately the in vivo situation, due to the lack in the mitochondrial fraction of essential cytosolic components and to the use of excess of substrates in the in vitro assays. An approach is described here whereby the control of respiration by cytochrome c oxidase (COX; EC 1.9.3.1) was analyzed in intact cultured human osteosarcoma 143B.TK- cells and other wild-type cells and in mitochondrial DNA mutation-carrying human cell lines. Surprisingly, in wild-type cells, only a slightly higher COX capacity was detected than required to support the endogenous respiration rate, pointing to a tighter in vivo control of respiration by COX than generally assumed. Cell lines carrying the MERRF mitochondrial tRNA(Lys) gene mutation, which causes a pronounced decrease in mitochondrial protein synthesis and respiration rates, revealed, in comparison, a significantly greater COX capacity relative to the residual endogenous respiration rate, and, correspondingly, a higher COX inhibition threshold above which the overall respiratory flux was affected. The observed relationship between COX respiratory threshold and relative COX capacity and the potential extension of the present analysis to other respiratory complexes have significant general implications for understanding the pathogenetic role of mutations in mtDNA-linked diseases and the tissue specificity of the mutation-associated phenotype.Keywords
This publication has 28 references indexed in Scilit:
- Catalytic Activity of Complex I in Cell Lines that Possess Replacement Mutations in the ND Genes in Leber's Hereditary Optic NeuropathyEuropean Journal of Biochemistry, 1996
- Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic NeuropathyJournal of Biological Chemistry, 1996
- Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat Brain MitochondriaJournal of Neurochemistry, 1996
- Increase of Flux Control of Cytochrome c Oxidase in Copper-deficient Mottled Brindled MiceJournal of Biological Chemistry, 1996
- Complex I deficiency is Associated with 3243G:C Mitochondrial DNA in Osteosarcoma Cell CybridsHuman Molecular Genetics, 1996
- MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation terminationNature Genetics, 1995
- The Sum of Flux Control Coefficients in the Electron‐Transport Chain of MitochondriaEuropean Journal of Biochemistry, 1994
- Routes of electron transfer in beef heart cytochrome c oxidase: is there a unique pathway used by all reductants?Biochemistry and Cell Biology, 1992
- Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNACell, 1988
- Generation of High δɛ in Respiring Submitochondrial Particles by Steady‐State Accumulation of Oxidized N,N,N′,N′‐Tetramethyl‐p‐phenylenediamineEuropean Journal of Biochemistry, 1979